Cryoprotective reagent
    5.
    发明授权
    Cryoprotective reagent 失效
    冷冻保护试剂

    公开(公告)号:US5071598A

    公开(公告)日:1991-12-10

    申请号:US448803

    申请日:1989-12-11

    IPC分类号: A01N1/02 C12N1/04

    摘要: Compositions for cryopreservation of phosphoglyceride-containing biological and synthetic membranes are provided in which a lipophilic anchor molecule is modified by the attachment of a preferably carbohydrate moiety placed at a predetermined, variable distance from the hydrophobic portion of the molecule by means of a hydrophilic linker unit. A method for the use of the compositions is also provided.

    摘要翻译: 提供了含有磷酸甘油酯的生物和合成膜的低温保存组合物,其中亲脂性锚定分子通过借助于亲水连接体单元连接到位于与分子的疏水部分预定的可变距离的优选碳水化合物部分进行修饰 。 还提供了使用该组合物的方法。

    Membrane immune assay
    8.
    发明授权
    Membrane immune assay 失效
    膜免疫测定

    公开(公告)号:US4581222A

    公开(公告)日:1986-04-08

    申请号:US465360

    申请日:1983-02-09

    IPC分类号: G01N33/534 A61K43/00 G01T1/00

    摘要: An immunoassay method for detection of antigen is disclosed. The method employs complement mediated lysis of vesicles loaded with In-111 or other gamma-emitting cation, and quantitative detection of the lysis by gamma-ray perturbed angular correlation (PAC) spectroscopy. The vesicles are labeled with a substance competitive to the antigen to be measured, and the concentration of the antigen in the sample measured by assessing the diminution in lysis due to the presence of the competing antigen.The method may also be used to assess the immunologic competence of a subject by injecting suitably sensitized vesicles and monitoring the in vivo lysis pattern by (PAC).

    摘要翻译: 公开了一种用于检测抗原的免疫测定方法。 该方法使用负载有In-111或其他γ发射阳离子的囊泡的补体介导的裂解,以及通过γ射线扰动角度相关(PAC)光谱定量检测裂解。 囊泡用与要测量的抗原竞争的物质标记,并且通过评估由于竞争性抗原的存在引起的裂解减少来测量样品中抗原的浓度。 该方法还可以用于通过注射适当敏化的囊泡和通过(PAC)监测体内裂解模式来评估受试者的免疫能力。

    Lipid vesicles bearing carbohydrate surfaces as lymphatic directed
vehicles for therapeutic and diagnostic substances
    9.
    发明授权
    Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances 失效
    含有碳水化合物表面的脂质囊泡作为治疗和诊断物质的淋巴导向载体

    公开(公告)号:US4310505A

    公开(公告)日:1982-01-12

    申请号:US92342

    申请日:1979-11-08

    摘要: Lipid vesicles comprising a lipid bilayer which includes analogs of cell-surface receptors such as dicetyl phosphate; stearylamine; 6-(5-cholesten-3.beta.-yloxy) hexyl 1-thio-.beta.-L-fucopyranoside; 6-(5-cholesten-3.beta.-yloxy) hexyl 1-thio-.beta.-D-galactopyranoside; 6-(5-cholesten-3.beta.-yloxy)hexyl 1-thio-.alpha.-D-mannopyranoside; 6-(5-cholesten-3-yloxy)hexyl 2-acetamido-2-deoxy-1-thio-.beta.-D-galactopyranoside; 6-(5-cholesten-3.beta.-yloxy)hexyl 6-amino-6-deoxy-1-thio-.beta.-D-galactopyranoside; or 6-(5-cholesten-3.beta.-yloxy)hexyl 6-amino-6-deoxy-1-thio-.alpha.-D-mannopyranoside; cholesterol and distearoyl phospatidylcholine, and an effective amount of physiologically compatible radioactive tracer, cytotoxic or therapeutic agent as a part of the vesicles. The vesicles of this invention can be administered to the human host and have been found to release the contents of the vesicles in a predetermined manner, i.e., controlled release, and in some cases, to be rapidly concentrated in the lymphatic system and/or liver, lungs or spleen of the host.

    摘要翻译: 包含脂质双层的脂质囊泡,其包括细胞表面受体的类似物,例如磷酸二鲸蜡酯; 硬脂胺 6-(5-胆甾烯-3β-氧代)己基1-硫代-β-L-吡喃葡萄糖苷; 6-(5-胆甾烯-3β-氧基)己基1-硫代-β-D-吡喃半乳糖苷; 6-(5-胆甾烯-3β-氧基)己基1-硫代-α-D-吡喃甘露糖苷; 6-(5-胆甾烯-3-基氧基)己基2-乙酰氨基-2-脱氧-1-硫代-β-D-吡喃半乳糖苷; 6-(5-胆甾烯-3β-氧基)己基6-氨基-6-脱氧-1-硫代-β-D-吡喃半乳糖苷; 或6-(5-胆甾烯-3β-氧基)己基6-氨基-6-脱氧-1-硫代-α-D-吡喃甘露糖苷; 胆固醇和二硬脂酰磷脂酰胆碱,以及有效量的生理相容的放射性示踪剂,细胞毒性剂或治疗剂作为囊泡的一部分。 本发明的囊泡可以施用于人宿主,并且已经被发现以预定的方式(即控制释放)释放囊泡的内容物,并且在一些情况下快速浓缩在淋巴系统和/或肝脏中 ,肺或脾脏的主机。